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Background: Palmitic acid, the most common saturated free fatty acid, has been implicated in ER (endoplasmic
reticulum) stress-mediated apoptosis. This lipoapotosis is dependent, in part, on the upregulation of the activating
transcription factor-4 (ATF4). To better understand the mechanisms by which palmitate upregulates the expression
level of ATF4, we integrated literature information on palmitate-induced ER stress signaling into a discrete dynamic
model. The model provides an in silico framework that enables simulations and predictions. The model predictions
were confirmed through further experiments in human hepatocellular carcinoma (HepG2) cells and the results were
used to update the model and our current understanding of the signaling induced by palmitate.
Results: The three key things from the in silico simulation and experimental results are: 1) palmitate induces
different signaling pathways (PKR (double-stranded RNA-activated protein kinase), PERK (PKR-like ER kinase), PKA
(cyclic AMP (cAMP)-dependent protein kinase A) in a time dependent-manner, 2) both ATF4 and CREB1 (cAMP-
responsive element-binding protein 1) interact with the Atf4 promoter to contribute to a prolonged accumulation
of ATF4, and 3) CREB1 is involved in ER-stress induced apoptosis upon palmitate treatment, by regulating ATF4
expression and possibly Ca2+ dependent-CaM (calmodulin) signaling pathway.
Conclusion: The in silico model helped to delineate the essential signaling pathways in palmitate-mediated
apoptosis.
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Elevated serum free fatty acids (FFA) and hepatic lipid
accumulation in non-adipose tissues can lead to cellular
dysfunction or cell death, due in part to the diversion of
unoxidized FFAs to nonoxidative pathways, resulting in
lipoapoptosis [1]. Excess amounts of nonesterified FFAs
that fail to convert to triglyceride in liver cells, enhance
the risk for hepatocellular lipoapoptosis, a pathogenic
feature observed in non-alcoholic steatohepatitis (NASH)
[2]. The mechanisms involved in FFA-induced toxicity
have remained unresolved, however recent studies suggest* Correspondence: krischan@egr.msu.edu
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reproduction in any medium, provided the orthat hepatic lipoapoptosis arises predominantly from FFA-
induced lipotoxic stress of intracellular organelles, in par-
ticular the endoplasmic reticulum (ER) and mitochondria
[3].
The ER is one of the largest organelles in the cells,
and perturbing ER homeostasis or inducing ER stress
has profound effects on cell survival. Cellular perturba-
tions, such as alterations in calcium storage in the ER
lumen or an imbalance in the luminal-oxidizing environ-
ment will cause ER stress. This stress is sensed by the
cells through three ER transmembrane proteins, inositol
requiring enzyme (IRE) 1α, PKR-like ER kinase (PERK),
and activating transcription factor (ATF) 6α [4]. They
activate signaling processes to restore ER homeostasis,
and are collectively termed the unfolded protein respon-
se (UPR). UPR signaling pathways coordinate cellular
response by down-regulating protein translation, enhan-
cing expression of ER chaperone proteins that promote. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the degradation of misfolded proteins. When these cor-
rective actions are insufficient to attenuate ER-stress, the
UPR switches to a pro-apoptotic mode. However, the
mechanisms regulating ER-stress-induced apoptosis have
not been clearly defined.
Of the ER transmembrane proteins, PERK is involved
in regulating both translation and transcription to return
the folding demand and capacity to homeostasis. Like
PKR (double-stranded RNA-activated protein kinase,
also known as eIF2αk2), one of the eukaryotic transla-
tion inhibition factor 2α (eIF2α) kinases, PERK (eIF2ak3)
also phosphorylates eIF2α at Ser 51, and phosphorylated
eIF2α impedes global translation initiation to decrease
the protein load in the ER [5]. However, activated eIF2α
paradoxically favors an increase in the translation of the
activating transcription factor-4 (ATF4), a member of
the activating transcription factor/the cAMP-responsive
element-binding protein (ATF/CREB) family of basic
zipper-containing proteins [6]. ATF4 binds to cAMP
response element (CRE; TGACGT(C/A)(G/A)) as a ho-
modimer to induce transcription of many pro-survival
genes that are involved in amino-acid metabolism, re-
dox reactions, stress response and protein secretion
[7,8]. Under sustained ER-stress, ATF4 activates CHOP
(C/EBP-homologous protein; also known as GADD153)
transcription by binding to the CCAAT/enhancer binding
protein (C/EBP)/ATF response element (CARE) sequen-
ces, likely as heterodimers with members of the C/EBP
family transcription factor. CHOP in turn inhibits the ex-
pression of anti-apoptotic Bcl-2 (B cell lymphoma 2) pro-
tein [9,10]. Concomitantly, CHOP forms a heteromeric
complex with the phosphorylated c-Jun to bind the PUMA
(p53-upregulated modulator of apoptosis) promoter
and contributes to the upregulation of pro-apoptotic
proteins [11].
Saturated long chain-FFAs, especially palmitic acid,
have been implicated in ER stress-induced apoptosis in
liver cells [12,13]. Since both transcriptional regulation
and translational control of ATF4 plays a central role on
ER stress-induced apoptosis, recent studies have focused
on the regulation of the ATF4 gene mediated by palmi-
tate. In H4IIE liver cells, a rat liver hepatoma cell line,
palmitate has been shown to induce ER stress, as evident
by increased mRNA levels of ATF4 [12-14]. Similarly
human hepatocarcinoma cell lines, such as HepG2 cells,
respond also to palmitate by elevating ATF4 mRNA and
inducing ER stress [15]. However, with the highly dy-
namic nature of UPR signaling, it would be judicious to
integrate signaling pathways which are involved in the
regulation of ATF4 and further elucidate the dynamics
of the main signaling axis for ER stress-induced apoptosis,
PERK/eIF2α/ATF4. The complexity of the signaling path-
ways involved makes it difficult to experimentally test allpossible interactions to determine which pathways in the
signaling network are functional for a given condition.
Therefore, we applied a discrete dynamic network model
to integrate potential interactions and components of ER
signaling and its feedbacks in HepG2 cells to gain a
better understanding of how palmitate induces ER stress
in liver cells. The predictions are confirmed with further
experiments.Results
The conventional signaling pathway (PERK/eIF2α/ATF4)
cannot explain the prolonged ATF4-dependent ER stress
induced by palmitate in HepG2 cells
To evaluate the dynamics of the conventional ER signal-
ing pathway, we measured the protein expression levels
of PERK, eIF2α, and ATF4 at 3, 6, and 24 hrs upon
palmitate treatment. As shown in Figure 1A, the phos-
phorylated protein levels of PERK at Ser 713 and eIF2α
at Ser 51 were signficantly increased by palmitate treat-
ment at 6, 24 hr and 3, 6 hr, respectively, while their
total protein levels remained constant. Palmitate transi-
ently increased the phosphorylation levels of eIF2α but
induced a sustained increase in the protein expression
level of ATF4. We note several discrepancies from the
conventional signaling pathway. First, although eIF2α is
activated transiently by palmitate, ATF4 continued to be
strongly induced by palmitate, i.e. remained stably upre-
gulated through 24 hrs (Figure 1B). In support of our
results, a recent study also observed similar trends in a
time-course analysis of eIF2α phosphorylation and ATF4
protein expression in HepG2 cells treated with thap-
sigargine, an ER calcium-ATPase pump inhibitor that
induces calcium release from the ER [16]. The eIF2α
phosphorylation was transientlty activated by thapsiga-
rine and reached a maxium at 30 min, while ATF4 in-
duction continued to rise for up to 8 hrs. However, it
remains unclear why ATF4 remained stably upregulated
even though the level of eIF2α phosphorylation was only
transiently activated.
In addition, our group recently found that cAMP pro-
moted apoptosis in palmitate-treated HepG2 cells, sug-
gesting that cAMP-CREB1 signaling may be involved in
palmitate-mediated ER stress [17]. Furthermore, it has
been shown that the phosphorylation of CREB1 can be
up-regulated by thapsigarine (ER stress inducer) in hu-
man glioma cells [18]. Since ATF4 (also known as CREB2)
belongs to a family of ATF/CREB proteins, it raises a pos-
sibility that crosstalk exists between these two proteins
during palmitate-induced ER stress. Therefore, we asses-
sed whether the phosphorylation of CREB1 in HepG2
cells is up-regulated upon palmitate treatment. As shown
in Figure 2, the phosphorylation of CREB1 was signifi-
cantly induced by palmitate at all time points (3, 6, 24 hr).
Figure 1 Effects of palmitate on the PERK- eIF2α-ATF4
pathway. (A) Western blotting analysis. HepG2 cells were treated
with 2% BSA (as a negative control) and 700 μM Palmitate (PA).
After 3, 6, 24 hrs, the cell extracts were collected and subjected to
immunoblot analysis for total PERK (both phosphorylated and non-
phosphorylated proteins), p-PERK (phosphorylated proteins), eIF2α,
p-eIF2α, and ATF4. Actin served as a loading control. (B)
Quantification. From Figure 1A, the phosphorylation levels of PERK
and eIF2α were quantified and normalized to the total protein levels
of PERK and eIF2α, respectively. The protein expression levels of
ATF4 were also quantified. The protein fold changes were calculated
at each time point using the following equation: (Protein expression
level)palmitate/(protein expression level)BSA. Data represent the mean
and standard deviation of three independent experiments: *p < 0.05
and **p < 0.01 vs. the control at each time point.
Figure 2 Effects of palmitate on CREB1 phosphorylation.
Western blotting analysis. HepG2 cells were treated with BSA (as a
negative control) and 700 μM Palmitate (PA). After 3, 6, 24 hrs, the
cell extracts were collected and subjected to immunoblot analysis
for total CREB1 and p-CREB1. Actin served as a loading control. The
level of p-CREB1 was quantified by normalizing to the levels of total
CREB and expressed as the average of three samples ± SD from
three independent experiments: *p < 0.05 and **p < 0.01 vs. the
control at each time point.
Cho et al. BMC Systems Biology 2013, 7:9 Page 3 of 13
http://www.biomedcentral.com/1752-0509/7/9To resolve these discrepancies from the conventional
pathway and incorporate our findings with the current
knowledge, we collected and integrated information from
the literature on palmitate-induced ER stress signaling,
with an emphasis on how ATF4 could be activated by
palmitate. We constructed a network of palmitate-indu-
ced signaling processes by collating the literature informa-
tion (Figure 3). We formularized the signaling network
into a discrete dynamic model. Our discrete dynamicmodeling approach was previously proposed and success-
fully applied to dissect the insulin signaling pathways in
the same human liver cell system [19]. We applied this
modeling and simulation method to the palmitate-treated
cells (see Methods), and integrated current knowledge
to generate a signaling network, which was probed in
silico to provide insight into the regulatory mechan-
isms involved.
PKR pathway is essential for eIF2α phosphorylation in
palmitate
Our simulation results suggest plausible dynamic profiles
of the network upon palmitate-stimulation (Figures 4A,
4B, 4C). The simulations are based on current knowledge
of the regulatory interactions between the components in
the network. We initially assume that the activation steps
(mostly phosphorylation/de-phosphorylation) of the dif-
ferent components are at similar time scales. As shown in
Figure 4A, CREB1 phosphorylation level was increased by
palmitate over the simulation time, which matched the
results obtained by western blotting analysis shown in
Figure 2. However, the simulation results show that eIF2α
and ATF4 were not activated by palmitate treatment
(Figure 4A), which is inconsistent with the experimen-
tal results of Figure 1. The in silico results suggest an
Figure 3 Signaling network of ATF4-dependent ER stress mediated by palmitate. Nodes are genes (proteins) possibly involved in the
palmitate-induced signaling processes. Each arc represents a regulatory interaction (either activation or inhibition).
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tate-induced signaling processes mediated by eIF2α and
ATF4.
Since PKR, another eIF2α kinase, has been shown to
be involved in ATF4-dependent ER stress in human em-
bryonic kidney cells [20], we questioned whether PKR is
involved in eIF2α phosphorylalion to regulate the pa-
mitate-mediated ATF4 protein expression in HepG2
cells. The experimental results suggest that PKR shows a
prompt response at 3 h (Figure 4D), while PERK takes
longer to be activated (6 h) (Figure 1). In addition, since
PKA (cyclic AMP (cAMP)-dependent protein kinase A)
regulates CREB1 phosphorylation both directly and in-
directly (through PP2A (nuclear protein phosphatase
2A)) [21,22], we measured the protein expression level
of PKA upon palmitate treatment. The catalytic subunits
of PKA, which plays an important role for PKA activa-
tion, were significantly upregulated at 24 hr (Additional
file 1: Figure S1). Thus we concluded that palmitate
initiates signaling at different times through PKR (3 hr),
PERK (6 hr), and PKA (24 hr). We subsequently incor-
porated this new information into the discrete dynamic
model, by imposing different delays in the palmitate-
induced PERK and PKA activation. The resultant eIF2α
profile (Figure 4B) matches the experimental observation
(Figure 1) of a transient elevation in its phosphorylation
level, which initiates the early ER stress response. The
network model thus suggests an important role of the
different response time of PKR vs. PERK in the regula-
tion of the downstream effectors of palmitate. Thus wehypothize that the prompt response of PKR could initi-
ate the signal that activates the eIF2α pathway.
CREB1 may be involved in ATF4-dependent ER stress
Another significant discrepancy between the in silico
simulation and the experimental observation lies in the
prolonged activation of ATF4. The experimental mea-
surements (Figure 1) show that ATF4 level is higher
(than control cells without palmitate treatment) at both
6 h and 24 h. Such a prolonged activation cannot be
explained by the model simulation where the ATF4 level
is reduced to lower than control at 24 h, although the
initial upregualtion of ATF4 in response to the upstream
eIF2α is captured by the model. The discrepancy sug-
gests the downsteam feedback regulation of ATF4 in the
current model is incorrect in our liver cell system. The
downstream feedback regulation in the model is media-
ted by phosphoprotein phosphatase 1 (PP1), which is
known as a major regulator of ATF4 [23]. We measured
the level of phosphorylated PP1 at different times upon
PA treatment and found that, in contrast to current
knowledge of the ATF4 pathway, there is no significant
change on the activity of PP1 (Additional file 1: Figure S2)
in our system that could affect the ATF4 level. The lack of
involvement of PP1 explains in part the discrepancy be-
tween the current knowledge and our experimental ob-
servation of ATF4 activation. Indeed, when we updated
our model with this new information of a constant PP1
level (i.e., to remove its impact on other components), the
ATF4 profile is no longer “inhibited” in the simulation
Figure 4 In silico simulation of the palmitate-induced signaling processes and effects of palmitate on PKR phosphorylation. (A)
Simulation model. The simulation is based on the systems model that includes the potential interactions and components from the literature,
and we further incorporate new observations obtained from experiments to refine the model. The downstream signals emphasized are the level
of eIF2α phosphorylation, CREB1 and ATF4 activity. Simulation results based on the network model in Figure 3 is an integration of the current
literature knowledge. (B) The difference in the response time of PKR and PERK is added into the model. (C) The knowledge that PP1 activity is
unchanged upon palmitate treatment is added into the model. (D) Western blotting analysis. The phosphorylated PKR level was measured using
western blotting analysis after 3, 6, 24 hr of palmitate treatment of HepG2 cells. Actin served as a loading control. The level of p-PKR was
quantified by normalizing to the levels of total PKR and expressed as the average of three samples ± SD from three independent experiments:
**p < 0.01 vs. the control at each time point.
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to capture the prolonged activation of ATF4, because
there is no other regulators that connect to ATF4 in the
model to support its sustained activation after 6 h. This
suggests that the current knowledge of the signaling pro-
cess is incomplete and there should be other (currently
unknown) regulatory relationship(s) in the network that
could lead to the accumulation of ATF4 and finally
lipoapoptosis.
CREB1 is of the same family as ATF4 and the phos-
phorylation of CREB1 was significantly enhanced upon
palmitate treatment (Figure 2). Multiple CRE binding
sites (TGACG or CGTCA) are identified on the ATF4
and CREB1 genes. Both CREB1 and ATF4 proteins could
bind the putative CRE binding sites to enhance their gene
expressions. Thus, we tested whether silencing either gene
affects the protein expression level of ATF4 and CREB1.
As shown in Figure 5A, CREB1 silencing significantlyreduced the protein expression of ATF4, while ATF4 si-
lencing did not significantly affect the protein expression
level of CREB1. From these results, we hypothesized that
both ATF4 and CREB1 regulate the gene expression of
ATF4. This potential crosstalk (Figure 5B) between ATF4
and CREB1 pathway was integrated into our system model
(Figure 3), and the simulation results (Figure 5C and 5D)
predict a prolonged activation of ATF4 level, with either
ATF4 binding to its own promoter, or CREB1 binding to
the Atf4 promoter to induce ATF4 gene expression.
ATF4 protein binds to the CRE site on the Atf4 promoter
in vitro
Since ChIP-chip data for pCREB1 are available, we de-
termined whether the CREB1 protein interacts with the
Atf4 promoter. The hepatocyte-specific ChIP-chip data
for pCREB1 binding on Creb1 and Atf4 promoters were
obtained from the CREB1 target gene database [24]. A
Figure 5 ATF4-CREB1 interactions. (A) Western blotting analysis. HepG2 cells were grown and transfected with ATF4 and CREB1 siRNA or
negative control siRNA for 24 h as described in Methods. After another 48 hr of culture in regular medium, the cell extracts were collected and
analyzed by western blot. Protein expression levels were quantified and displayed as fold-changes as compared to the loading control in the bar
graph. Data are presented as means ± SD from three independent experiments: *p < 0.05 and **p < 0.01 vs. the control. (B) Potential model of
ATF4-CREB1 interactions. (C) and (D) The simulation is based on the modified model that incorporates the results of Figures 4 and 5. The
simulation results shows the predicted dynamic profile with (C) active CREB1 protein binding to the ATF4 promoter to induce ATF4 transcription,
and (D) ATF4 protein binding to its own promoter to induce transcription.
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p-value ≤ 0.001 was used to determine pCREB positive
promoters (see ref [24] for details). ChIP-chip data showed
that both ATF4 (binding ratio = 3.1, p-value = 4.1e-06) and
CREB1 (binding ratio = 2.1, p-value = 8.3e-04) are positive
for pCREB1 in hepatocytes, suggesting that the CREB1
protein directly binds on both the Creb1 and Atf4 promo-
ters. In addition, to experimentally examine whether the
ATF4 protein interacts with the Atf4 promoter, we de-
signed an ATF4 probe (-175 to -147) which contains one
CRE site (CGTCA; -164 to -160) and performed an EMSA
assay. As shown in Figure 6, the ATF4 probe formed a
DNA-protein complex with the nuclear extract from the
palmitate-treated HepG2 cells (lane 2; marked as an
arrow). The IgG antibody does not cause any significant
change of the DNA-protein complex (lane 3), while the
ATF4 antibody eliminated the complex (lane 4). Since thedisappearance of a band by the addition of a specific anti-
body, but without a supershift, provides evidence of DNA-
protein complex [23,25], our results suggest that the ATF4
protein directly binds to the CRE site on the Atf4 pro-
moter. Thus, the ChiP-chip data and our EMSA data con-
firmed our potential models in Figure 5C and 5D,
supporting that both ATF4 and CREB1 proteins could
regulate the ATF4 gene expression.
In-silico perturbation study suggests the essential
signaling pathways for ATF4 and CREB1 activation
mediated by palmitate
To identify the essential signaling pathways of ATF4 and
CREB1 activated by palmitate, we simulated a model that
incorporated our experimental findings and then evalu-
ated the dynamics of eIF2α phosphorylation, ATF4 ex-
pression, and CREB1 phosphorylation, by systematically
Figure 6 EMSA of the Atf4 promoter region using palmitate-
treated cell extracts. Prior to nuclear extract isolation, HepG2 cells
were incubated for 24 h in 0.7 mM palmitate conjugated 2% BSA.
EMSA analysis to monitor binding to the CRE site (CGTCA; −164
to −160) was performed as described in Methods section. The first lane
marked ‘−’ contains the probe alone and the second lane marked ‘+’
contains the probe and the nuclear extract. The remaining lanes
contain antibodies in addition to the probe and the nuclear extract.
Arrow represents a complex of ATF4-the DNA probe.
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p38, Ca2+ activation regulated by palmitate are essential
for CREB1 phosphorylation. The in silico knock-out re-
sults (Additional file 1: Figure S3) showed that PKA-
CREB1 and p38-CREB1 interactions did not alter the
dynamics of the model. However, the deletion of Ca2+
signaling dramatically reduced CREB1 phosphorylation
(marked by an arrow in Additional file 1: Figure S3). The
model further showed that the PKA-, p38-, Ras-deficient
model was able to capture the dynamic response of
CREB1 and ATF4, as long as the Ca2+ signaling was able
to induce CREB1 phosphorylation in response to the pal-
mitate treatment. It has been shown that Ca2+ depen-
dent-calmodulin (CaM) plays an important role in the
activation of the CREB1 pathway [26,27], and our simula-
tion results suggest that the calcium signaling pathway
should be an essential component in the signaling net-
work in response to palmitate stimulation of the liver cells.
In other words, calcium signaling is sufficient to acti-
vate CREB1 phosphorylation, without the other path-
ways, and to recapitulate the dynamic behavior observed
experimentally.
Since PKR and PERK are two main upstream signa-
ling components of ATF4, we further evaluated whether
knock-out of either PKR or PERK perturbs the signaling
dynamics of ATF4. Simulation results (Figure 7A) sug-
gest that the differences between PKR and PEKR per-
turbations (inhibitions) show up at an early time step
(within 10 time steps, which correspond to ~6 hr in
experimental time, according to the experiments in
Figure 1 and the simulation results in Figures 4 and 5).
The ATF4 level under PKR-silencing decreased much more
significantly than the level under PERK-silencing in the
earlier time point (e.g. at 5 time-steps, captured at ~3 hr
in experimental time). This subtle difference comes from
the underlying mechanism of the regulatory network
where PKR and PERK plays different roles (i.e. palmitate
initiates the PKR-eIF2α-ATF4 pathway through PACT-
PKR activation at an earlier time then PERK), and is cap-
tured by the model. Our experimental results confirm this
difference (Figure 7B and C), that PKR-knockdown cells
showed significantly lower ATF4 gene expression level at
the earlier time point (3 hr), while PERK-knockdown
started to reduce the ATF4 gene expression level at a later
time (6 hr). These results are consistent with the in-silico
simulations (Figure 7A), suggesting that PKR is respon-
sible for the early activation of ATF4. In addition, since ER
stress in human embryonic kidney cells has been shown
to involve the activation of PKR by PACT (PKR activating
protein) [20], we experimentally tested whether PACT si-
lencing blocks ATF4 mRNA expression levels. Treating
the cells with palmitate for 3 hr resulted in a significant
decrease in the ATF4 gene expression (Figure 7C), sug-
gesting that the PACT-PKR pathway is essential for the
Figure 7 Breakdown of the PKR-ATF4 or PERK-ATF4 signaling. (A) In silico knock-out of PKR and PERK. The essential model includes PKR,
PERK and Ca2+ pathways as the downstream responders to palmitate stimulation. In silico simulation is performed on the essential model and
compared with a model wherein either PKR or PERK is knocked-out. (B) and (C) Real-time quantitative RT-PCR analysis: (B) Knockdown of PKR and
PERK gene expression and (C) knockdown of PACT gene expression. HepG2 cells were grown and transfected with siRNA of PKR, PERK, and
PACT or negative control siRNA for 24 hr as described in the Methods. The cells were incubated for 3 and 6 hr in media containing BSA or
BSA-complexed palmitate. The total mRNA were extracted and transcribed into cDNA. mRNA expression levels were quantified by real-time
quantitative RT-PCR analysis and displayed as fold-changes as compared to the control samples treated with BSA in the bar graph. Data are
presented as mean ± SD from three independent experiments: *p < 0.05 and **p < 0.01 vs the control at each time point. A line indicates
comparison between the 2 bars connected by the line.
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stress response. Based on our computational analysis and
experimental results, we identified the essential pathways
involved in activating ATF4 and CREB1 in HepG2 liver
cells upon palmitate treatment (Figure 8).
Discussion
Increased long-chain saturated fatty acids, a characte-
ristic feature of obesity and NASH [28], can induce ER
stress, activate the UPR, and lead to cell death in hepa-
tocytes [12,13]. Increasing number of studies implicate
an involvement of palmitate in ER stress-induced apop-
tosis in liver cells [11-14,29,30], but the mechanism by
which palmitate regulates the UPR signaling pathways is
unclear. The present study sought to determine which
signaling pathways are essential for the activation of
ATF4, which plays a crucial role as a mediator of ER
stress-induced apoptosis.
PKR, an eIF2α kinase, has recently emerged to be in-
volved in ER stress-induced apoptosis by pharmacologicalER inducers, thapsigargine and tunicamycin [20,31,32].
Lee et al. found that activated PKR phosphoryla-
ted the eIF2α in a PERK-independent manner when
HEK293A cells were treated with thapsigargine [20].
They showed that PKR was responsible for approxi-
mately 40% and PERK for over 50% of the total phos-
phorylated eIF2a at 12 h upon thapsigargin treatment.
However, our study suggests that the contributions of
PKR and PERK on eIF2α phosphorylation change in a
time dependent-manner upon palmitate treatment. At
an earlier time (3 hr), PKR is entirely responsible for
eIF2α phosphorylation (Figure 4D), with PERK adding
to this contribution, to the eIF2α phosphorylation, at
6 hr (Figure 1). The relative contributions of PKR
and PERK on eIF2α phosphorylation would also de-
pend on the types of inducers and cells [20,33,34]. It
would be worthy in future to investigate the kinetics
of PKR and PERK activations to obtain more infor-
mation on the roles of PKR and PERK-dependent ER
stress.
Figure 8 Essential signaling network of palmitate-induced ATF4 expression. The direct interactions between p38-CREB1 and Ras-CREB1 are
deleted. The PP1 feedback to eIF2α is removed. Along with the essential feedback structure between ATF4 and CREB1, three main downstream
signaling pathways are summarized: 1) Early response with PACT-PKR and PERK, 2) Slower response with PKA and 3) Ca2+ signaling.
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on eIF2α phosphorylation, a negative feedback loop could
relieve the translational inhibition during ER stress,
through GADD34-mediated PP1 activation [35-37]. ATF4
has been shown to bind specifically to a conserved ATF
site on the GADD34 promoter in a stress-dependent man-
ner. GADD34 in turn binds and activates the PP1 protein,
which leads to eIF2α dephosphorylation and the resump-
tion of general translation. In contrast to the conventional
mechanism, we found that palmitate did not promote PP1
phosphorylation and the negative feedback mechanism
was not activated in the palmitate-induced ER stress in
HepG2 cells. Blockage of the negative feedback by palmi-
tate may promote ATF4 accumulation in the cells while
maintaining a normal level of eIF2α phosphorylation. In
keeping with the concept of our study, a recent report
suggested that salubrinal (well known as an eIF2α inhibi-
tor) interrupts the feedback mechanism by inhibiting
GADD34/PP1 complex activity, thereby potentiating pal-
mitate-induced ER stress in pancreatic β-cells [38]. Similar
to the synergistic roles of salubrinal and palmitate in
β-cells, palmitate alone may be sufficient to induce ER
stress-induced apoptosis in HepG2 cells [17,39].
ATF4 is known to form homo and heterodimers for
DNA binding [40]. One study showed that ER stress
induces a complex formation between endogenous
ATF1/CREB1 and ATF4, subsequently binding to the
ATF/CRE site of the Grp78 promoter [41]. Along
with the ChIP-chip data [24], one group recently sug-
gested that CREB1 is able to bind the CRE site(CGTCA ; −921 to −917 ) on the Atf4 promoter and a
constitutively active PKA catalytic subunit dramatically
activated Atf4 promoter through PKA-CREB1 signaling
[23]. Consistent with this study, our experimental and
computational data showed that PKA activated by palmi-
tate at a later time (24 hr) upregulates CREB phosphoryl-
ation, subsequently inducing the ATF4 expression. In
addition, our EMSA data suggested that ATF4 protein
binds its own Atf4 promoter region containing the CRE
site (CGTCA ; −164 to −160) and the positive-feedback
stabilizes the ATF4 expression. Upon palmitate treatment,
PKA or Ca2+-dependent CaM signaling pathways could
enhance the interaction of CREB1 alone or the ATF4/
CREB1 heterodimer with the Atf4 promoter to prolong
ATF4 accumulation. Although these remain open ques-
tions, our findings suggested that both ATF4 and CREB1
binding on the Atf4 promoter plays an important role in
prolonging ATF4 accumulation upon palmitate exposure.
In this study, our in silico model provides a framework
to integrate regulatory information into a complex net-
work and test the network for consistency by comparing
the dynamic simulations with experimental measure-
ments. Our simulations show inconsistencies between
current knowledge of the network and our observation
of palmitate-induced ER stress in the liver cells, which
led us to explore the temporal response of the different
pathways (e.g. PACT-PKR, PERK, PKA) to palmitate
stimulation. This led to the identification of an essential
feedback structure in the downstream ATF4/CREB1 regu-
lation that differs from the conventional understanding of
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ning process in which we begin by integrating the current
knowledge to build a model to generate hypothesis, which
is tested with experiments to obtain novel information.
The new information is then incorporated into the net-
work model to correct and update our understanding of
the regulation. The updated model can be used to guide
new experiments, thereby forming an iterative process
that can systematically be applied to study biological pro-
cesses. The discrete dynamic modeling approach de-
veloped in [16] for signaling network was expanded to
account for transcriptional regulation by introducing de-
lays into the regulation. New data and new information
could be easily incorporated by adding delays (temporal
information), altering gene activity states (perturbations
with activator/inhibitor) or the network wiring (binding
information), as demonstrated in this study of the regula-
tory network underlying palmitate-induced ER stress. This
systems biology approach can be applied to other bio-
logical process to elucidate the molecular mechanism
underlying the regulatory network by integrating experi-
mental measurements and computational simulation.
Conclusions
Integrating experiments and computational simulations
helped to identify several notable findings, summarized
in Figure 8. First, the dynamics of the signaling profiles
show that palmitate initiates the PKR-eIF2α-ATF4 path-
way through PACT-PKR activation at an earlier time
and PERK later helps to maintain eIF2α phosphoryl-
ation. Second, ATF4 and CREB1 bind the Atf4 promoter
to contribute to a prolonged ATF4 accumulation and
their feedbacks appear necessary for ER-stress induced
apoptosis. Third, palmitate responds later to PKA activa-
tion and possibly along with the Ca2+ dependent-CaM
signaling pathway to increase CREB1 phosphorylation.
Thus this systems biology approach helped provide in-
sight into the molecular mechanisms by which palmitate
induces ER stress in liver cells.
Methods
The discrete dynamic modeling of biological network
We applied the approach of discrete dynamic modeling
proposed in our previous study [19]. The model is con-
structed based on the topology and the regulatory rela-
tionships within a given network, with basic assumption
that the network architecture defines the major dynamic
characteristics of the system. We associate each compo-
nent (protein) in the network with a discrete variable
with three potential states (0: lower than control, 1: the
control state, 2: higher than control), and simulate the
system with transition rules (shift-up or shift-down)
depending on the regulatory relationships between the
components (activation or inhibition). More specifically,if an activator is in a state 2, (for example, a kinase is
activated), the state of its target gene will be shifted up-
wards, from 0 to 1, or 1 to 2, depending on the target
gene’s current state. In contrast, if the state of an inhi-
bitor is higher than control, its target will be shifted
downwards in the next updating event. The state of a
component will decay (back to control state 1) if its reg-
ulators can no longer maintained their active state.
Given this transition rules and a specific initial state of
the system, we can compute a series of “state-changes”
for each component along discrete time steps, where the
current state of the system (i.e. the state of each compo-
nent in the current time-step) depends on the both the
previous states (i.e. states in the previous time-steps) as
well as the transition process which imposes transition
rules based on regulatory relationships within the net-
work. Since the reaction rates may be different from cell
to cell even for the same interaction, we apply asynchron-
ous updating of the state, which is realized immediately,
rather than renewing every variable simultaneously at each
time-step. Thus, the relative rates of the different reactions
can be specified by the ordering of the update, which im-
plies that, although the response may be similar, the rate
of response varies from cell to cell, or, between different
runs. We perform 5,000 independent runs in each simula-
tion to mimic a cell population that is measured by west-
ern blotting or RT-PCR experiments. We impose a
distribution of initial states (centered at the control state
1) and a randomization of the ordering of the updates to
represent cell-cell variation. The dynamic model was
implemented by custom MATLAB code.
Two novel properties are introduced to the original
modeling approach in [19] to extend the methodology to
address different time-frames and to refine the model with
posterior information (novel experimental observations).
1) Delayed processes. To deal with certain regulatory
interactions that are expected to respond much
slower than other signaling processes, such as
transcription, translation, and the slower response of
PERK upon palmitate treatment, we introduce a
delay on these interactions such that the current
state of the targeted gene depends on not the last
state but an earlier previous state of its activator/
inhibitor. Therefore, different from the original state
transition: Si = f(Si-1), in which the current system
state Si depends on the system state of the last step
Si-1, our new approach does not apply this Markov
assumption, and instead Si = f(Si-1, Si-2, . . . S1), which
could present a history-dependent dynamics. In
practice, we implement the idea by simply
introducing multiple intermediate (virtual)
components in between the regulator and its targets
to delay the signal transduction.
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information, such as time-separation of the
interactions, or the measurement of the activity of
particular component in the network, could be
incorporated to refine the model by adding
constraints to the simulation. The constraints could
be a delay of a certain interaction, or impose a
constant value of activity on certain components
(e.g. PP1) during the simulation.
The discrete dynamic model is based on the simple
logic (activation/inhibition) in a regulatory network,
which corresponds to our current (mostly
qualitative) understanding in this biological system.
We measure the average gene expression level in an
“in silico” cell population that has varying initial
states and order of reactions, to enhance the
robustness of the simulation results. The Additional
file 1: Figure S4 shows the increase in robustness of
the model when a larger sample size is applied.
There are variances in the different replicates of the
simulation when the sample size is small, e.g. 50 runs
(Additional file 1: Figure S4). These differences come
from the randomness of the initiation (i.e. initial
states) and the shuffling of the reactions, which are
not related to the regulatory mechanism that is being
modeled. By increasing the sampling size, the model
becomes more robust. With 5000 runs, the different
initial states or order of reaction have no effect on
the averaged response curve, thus any differences
that is observed between the different perturbations
should reflect changes in the regulation imposed by
the perturbation.
Cell culture and reagents
HepG2/C3A human hepatocellular carcinoma cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum and 1% of
penicillin–streptomycin (penicillin: 10,000 U/ml, strepto-
mycin: 10,000 μg/ml; Invitrogen) in a humidified incuba-
tor at 37°C and 5% CO2. Sodium palmitate was purchased
from Sigma. In all experiments, palmitate (0.7 mM) was
complexed to 2% (w/v) fatty acid free BSA (US Biologi-
cals) dissolved in regular medium. For palmitate treat-
ment, HepG2 cells were seeded in the 6-well plate and
cultured until 90% confluence.
RNA interference and reverse transfection
SiRNAs targeting human PACT (50-GAGAGAAUAUA
CUACAAUUTT-30 and 50-AAUUGUAGUAUAUUCUC




CREB1 (50-CCGUAACUCUAGUACAGCUTT-30 and 50-AGCUGUACUAGAGUUACGGTG-30) were purchased
from Ambion. SiRNAs targeting human ATF4 (siGE-
NOME SMARTpool #M-005125-005) was purchased
from Dharmacon. The scrambled non-targeting siRNA
(Ambion), used as a negative control, or the siRNA tar-
geting proteins was diluted in Opti-MEM (Invitrogen)
and then mixed with the transfection reagent, Lipofecta-
mine RNAiMAX (Invitrogen). The mixture of siRNA
and Lipofectamine RNAiMAX in Opti-MEM was then
added into six well plates and incubated at room tem-
perature for 20 min. 6 × 105 HepG2 cells were suspended
in antibiotic-free medium, seeded into 6-well plates, and
cultured for 24 hr. After transfection, the cells were
incubated in regular medium or palmitate-containing
medium and then collected for further analysis.Real-time quantitative RT-PCR analysis
Total RNA was extracted from cells with the RNeasy
mini kit (Qiagen). One microgram of total mRNA was
reverse-transcribed using an iScript cDNA synthesis kit
(Bio-RAD). The first-strand cDNA was used as a tem-
plate. The primers used for quantitative RT-PCR ana-
lyses of human ATF4 (50-TGGACTTCGAGCAAGAGA
TG-30 and 50-AGGAAGGAAGGCTGGAAGAG-30) and
human actin (50-ACATCGCCCTGTGGATGACT-30, and
50-TCACTTGTGGCCCAGATAGG-30) were synthesized
by Eurofins MWG Operon. Amplifications of the cDNA
templates were detected by SYBR Green Supermix (Bio-
Rad) using RT-PCR Detection System (Bio-Rad) and the
cycle threshold values were determined by the MyIQ soft-
ware (Bio-Rad). Each sample was performed in triplicate
and normalized to the actin expression levels.Western blot analysis
The HepG2 cells were washed twice with cold PBS
and treated with CelLyticM cell lysis buffer (Sigma-
Aldrich) or RIPA buffer (50 mM Tris (pH 8.0),
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS) supplemented with protease inhibitor cock-
tail (Sigma-Aldrich) for 10 min on ice. The cell lysate
was clarified by centrifugation at 13000 rpm for
10 min, and the supernatant was collected. Total pro-
tein levels were quantified by Bradford assay (Bio-Rad).
Thirty micrograms of total protein was loaded onto
9% SDS-PAGE gel, transferred to nitrocellulose mem-
branes, and probed with antibodies for target proteins:
PERK (Cell Signaling), p-PERK (BioLegend), eIF2a
(Cell signaling), p-eIF2a (Cell signaling) ATF4 (Santa
Cruz Biotechnology), CREB (Santa Cruz Biotechnol-
ogy), p-CREB (Cell signaling), PKR (Novus Biologicals),
and p-PKR (Novus Biologicals). The image was ana-
lyzed using the Molecular Imager ChemiDoc XRS System
from Bio-Rad.
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mobility shift assay)
Nuclear extracts were prepared as described in the litera-
ture [42]. 0.7 mM palmitate-treated HepG2 cells (24 hr)
were washed with ice-cold PBS, resuspended in Buffer
(10 mM HEPES (pH 8.0), 1.5 mM MgCl2, 10 mM KCl,
1 mM DTT, 50 mM NaF, 1 mM orthovanadate, 1
complete protease inhibitor mini tablet/10 mL), and left
to swell on ice for 15 min. Cells were then lysed by forcing
them through a 25-gauge hypodermic needle 6-8 times.
Lysate was centrifuged at 4000 g for 5 min to pellet the
crude nuclear fraction. The nuclear pellet was then resus-
pended in Buffer (20 mM HEPES (pH 8.0), 420 mM NaCl,
1.5 mM MgCl2, 25% glycerol, 0.2 mM EDTA, 1 mM DTT,
50 mM NaF, 1 mM orthovanadate, 1 complete protease
inhibitor mini tablet /10 mL) and incubated on ice for
30 min with gentle agitation. The nuclear extract was
spun down at 16000 g for 15 min to pellet the nuclei. The
supernatant was saved and used for EMSA.
A synthetic oligo representing −175 to −147 (ACTC
CTTTTCTCGTCACAGCTACGCCCT) of the ATF4 pro-
moter was used for EMSA. The probe was biotinylated
with Biotin 30-end DNA Labeling Kit from Thermo Scien-
tific. EMSA method was modified from the previous study
[43]. 5 μg of nuclear extract was incubated in EMSA buf-
fer (10 mM HEPES (pH 7.9), 50 mM KCl, 1 mM MgCl2,
1 mM EDTA, 0.1% NP-40, 50 mM NaF, 1 mM Orthova-
nadate) with 2 μg of ATF4 antibody for 1 hr on ice. The
biotinylated DNA probe was added to each mixture (with
the DNA probe only as a negative control and the DNA
probe with nuclear extract as positive control) and incu-
bated for 30 min at room temperature. The reactions were
loaded on a 4-20% TGX gel and separated by gel electro-
phoresis. The gel was then transferred on to a nylon mem-
brane and UV crosslinked with a hand held crosslinker for
10 min at 254 nm. The probe was then visualized using
the Chemiluminescencent Nucleic Acid Detection Mo-
dule from Thermo Scientific.
Additional file
Additional file 1: Contains experimental and computational
simulation results: Figure S1. The protein expression levels of PKAc
(PKA catalytic subunits) upon palmitate treatment, Figure S2. The protein
expression levels of PP1 upon palmitate treatment, Figure S3. In silico
knock-out of signaling pathways for CREB1 activation, Figure S4.
Simulation of the discrete dynamic model with different amount of
independent sampling size.
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